Skip to main content
RLYB
NASDAQ Life Sciences

5AM Ventures Significantly Reduces Stake in Rallybio Corp Post-Reverse Split

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$7.54
Mkt Cap
$39.815M
52W Low
$1.761
52W High
$7.78
Market data snapshot near publication time

summarizeSummary

Institutional investor 5AM Ventures sold approximately $983,000 worth of Rallybio Corp shares, significantly reducing its stake after the recent reverse stock split.


check_boxKey Events

  • Significant Share Sales by Institutional Investor

    5AM Ventures sold a total of 162,052 shares of Rallybio Corp common stock in open market transactions on February 25 and 26, 2026.

  • Substantial Value of Sales

    The sales generated approximately $983,000 in proceeds, representing a significant reduction in the investor's position.

  • Post-Reverse Stock Split Activity

    These transactions occurred shortly after Rallybio Corp's 1-for-8 reverse stock split, which was effective on February 2, 2026, and was intended to help the company meet Nasdaq's minimum bid price requirement.

  • Reduced Beneficial Ownership

    Following these sales, the 5AM Ventures group's aggregate beneficial ownership in Rallybio Corp has been significantly reduced to 5.5% of the outstanding common stock.


auto_awesomeAnalysis

5AM Ventures, a major institutional investor, has significantly reduced its stake in Rallybio Corp by selling approximately $983,000 worth of shares. These sales, representing over 2.4% of the company's market capitalization and more than 50% of 5AM Ventures' reported aggregate holdings, occurred shortly after the company's 1-for-8 reverse stock split. This substantial reduction by a key investor, following a critical corporate action aimed at maintaining Nasdaq listing, could signal a lack of long-term conviction and may exert further selling pressure on the stock.

At the time of this filing, RLYB was trading at $7.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $39.8M. The 52-week trading range was $1.76 to $7.78. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed RLYB - Latest Insights

RLYB
Apr 24, 2026, 4:38 PM EDT
Filing Type: S-4/A
Importance Score:
9
RLYB
Mar 16, 2026, 5:53 PM EDT
Filing Type: S-4
Importance Score:
9
RLYB
Mar 16, 2026, 5:18 PM EDT
Filing Type: 10-K
Importance Score:
9
RLYB
Mar 03, 2026, 4:34 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
RLYB
Mar 02, 2026, 9:31 AM EST
Filing Type: 8-K
Importance Score:
10
RLYB
Mar 02, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
9
RLYB
Feb 27, 2026, 4:45 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
RLYB
Jan 29, 2026, 5:14 PM EST
Filing Type: 8-K
Importance Score:
8
RLYB
Jan 02, 2026, 4:07 PM EST
Filing Type: DEF 14A
Importance Score:
8